- 全部删除
- 您的购物车当前为空
Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression.
Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 1,467 | 5日内发货 | |
10 mg | ¥ 2,467 | 5日内发货 | |
25 mg | ¥ 4,467 | 5日内发货 | |
50 mg | ¥ 8,467 | 5日内发货 | |
100 mg | ¥ 14,467 | 5日内发货 | |
200 mg | ¥ 22,467 | 5日内发货 |
产品描述 | Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression. |
别名 | Ac-Arg-Aib-Arg-α(Me)Phe-NH2 |
分子量 | 617.756 |
分子式 | C28H47N11O5 |
CAS No. | 1006388-38-0 |
密度 | 1.34 g/cm3 (Predicted) |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容